Join Us for Orion’s Capital Markets Day
ORION CORPORATION
INVESTOR NEWS
APRIL 2025
Orion Corporation is excited to announce its upcoming Capital Markets Day, welcoming analysts, institutional investors, bankers, and media representatives. This important event will take place on a Thursday in May 2025.
The venue for this gathering will be Event Venue Eliel, located on Töölönlahdenkatu 2. Participants can expect an engaging afternoon where Orion’s President & CEO, Liisa Hurme, along with CFO René Lindell and other key members of the Executive Management Board, will delve into the company’s growth strategy, financial objectives, and various business ventures.
Attendees will have the chance to ask questions during the event, fostering an interactive and informative experience. For those unable to attend in person, there is an option to participate via a live webcast starting at 1:00 PM EEST, ensuring global access to this pivotal discussion.
What to Expect During the Event
Throughout the session, Orion's leadership team will present insights regarding their strategic initiatives and vision for the future. Information on how to access the live stream will be provided, ensuring that everyone can join regardless of their location. Additionally, a recording of the event will be made available shortly after it concludes.
Presentation materials will be accessible on Orion’s website in the morning on the day of the event, allowing participants to review key points and information highlighted during the discussions. The presentations will be conducted in English, aligning with the company’s commitment to transparency and open communication.
Agenda Highlights
Here’s a closer look at the planned agenda for Orion’s Capital Markets Day:
- 12:45 PM EEST: Registration
- 1:00 PM EEST: Event and webcast begins
- 1:05 PM EEST: Presentations from key leaders:
- Liisa Hurme, President and CEO
- Outi Vaarala, Executive Vice President, Innovative Medicines and Research & Development
- Hao Pan, Executive Vice President, Branded Products
- Q&A Session
- BREAK
- Satu Ahomäki, Executive Vice President, Generics and Consumer Health
- Niclas Lindstedt, Executive Vice President, Animal Health
- René Lindell, CFO
- Q&A Session
4:30 PM EEST: Event concludes
The agenda is subject to modifications, and a more detailed schedule will be shared as we approach the event date.
How to Register
For those planning to attend in person, it is essential to register by the mid-May 2025 deadline. Due to limited seating, spots will be filled on a first-come, first-served basis, emphasizing the importance of early registration to secure attendance.
Contact Information
If you have any queries regarding the event, please reach out to Tuukka Hirvonen in Investor Relations, Orion Corporation, at +358 10 426 2721.
As a leading Nordic pharmaceutical company, Orion has dedicated over a century to enhancing well-being. The company specializes in developing, manufacturing, and marketing both human and veterinary pharmaceuticals, alongside various active ingredients. With a robust portfolio of proprietary and generic medications, Orion focuses its R&D efforts in crucial areas such as oncology and pain management. In the previous fiscal year, Orion achieved remarkable net sales and continues to employ a skilled team of professionals dedicated to advancing health initiatives worldwide. Orion's A and B shares are both listed on Nasdaq Helsinki, further demonstrating the company’s commitment to growth and transparency.
Frequently Asked Questions
What is Capital Markets Day?
Capital Markets Day is an event where companies share their strategic vision and financial performance with investors and analysts.
Who can attend the event?
Analysts, institutional investors, bankers, and media representatives are invited to attend this exclusive event.
Will there be an opportunity to ask questions?
Yes, attendees can engage in Q&A sessions during the presentations.
How can I register for the event?
Registration must be completed via the provided link before the registration deadline.
What are Orion's main therapeutic areas of focus?
Orion focuses primarily on oncology and pain management within its research and development efforts.
